Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Richtig Georg |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2023

Kurzbericht/Letter

** Buchacher, L; Richtig, G; Dernoscheg, M; Richtig, E; Koch, L Permanent dose reduction due to adverse reactions does not decrease efficacy of BRAF/MEK inhibition in metastatic melanoma.
J Eur Acad Dermatol Venereol. 2023; Doi: 10.1111/jdv.18871
Web of Science PubMed FullText FullText_MUG

 

2022

Kurzbericht/Letter

** Buchacher, L; Richtig, G; Schöffl, C; Richtig, E; Koch, L Long-term adherence to melanoma follow-up examinations - a telephone survey.
J Eur Acad Dermatol Venereol. 2022; 36(9):e710-e712 Doi: 10.1111/jdv.18177
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Dankner, M; Wang, Y; Fazelzad, R; Johnson, B; Nebhan, CA; Dagogo-Jack, I; Myall, NJ; Richtig, G; Bracht, JWP; Gerlinger, M; Shinozaki, E; Yoshino, T; Kotani, D; Fangusaro, JR; Gautschi, O; Mazieres, J; Sosman, JA; Kopetz, S; Subbiah, V; Davies, MA; Groover, AL; Sullivan, RJ; Flaherty, KT; Johnson, DB; Benedetti, A; Cescon, DW; Spreafico, A; Zogopoulos, G; Rose, AAN Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors.
JCO Precis Oncol. 2022; 6:e2200107 Doi: 10.1200/PO.22.00107
PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Wagner, N; Lenders, MM; Kuhl, K; Reinhardt, L; Fuchss, M; Ring, N; Richtig, G; Ebel, C; Andre, F; Stager, R; Zellweger, C; Sturmer, SH; Lang, R; Paar, M; Gussek, P; Kimeswenger, S; Oellinger, A; Amaral, T; Forschner, A; Leiter-Stoppke, U; Weide, B; Gassenmaier, M; Schraag, A; Klumpp, B; Hoetzenecker, W; Ziemer, M; Berking, C; Mangana, J; Nguyen, VA; Terheyden, P; Richtig, E; Loquai, C; Diem, S; Cozzio, A; Rocken, M; Garbe, C; Gebhardt, C; Meier, F; Eigentler, T; Flatz, L Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice
J DTSCH DERMATOL GES. 2022; 20: 3-4.-32. Deutschen Hautkrebskongresses (ADO‐Jahrestagung), 14.–17. September 2022; Sep 14-17, 2022; Hannover, Deutschland. [Poster]
Web of Science

 

2021

Originalarbeit (Zeitschrift)

** Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakić, E; Richtig, G; Richtig, E; Rohrer, PM; Koch, L; Wolf, IH; Koch, C; Rainer, BM; Koeller, M; Pichler, M; Gerritsmann, H; Kashofer, K; Aigelsreiter, A Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study.
Cancers (Basel). 2021; 13(12): Doi: 10.3390/cancers13123101 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Grübler, MR; Zittermann, A; Verheyen, ND; Trummer, C; Theiler-Schwetz, V; Keppel, MH; Malle, O; Richtig, G; Gängler, S; Bischoff-Ferrari, H; Scharnagl, H; Meinitzer, A; März, W; Tomaschitz, A; Pilz, S Randomized trial of vitamin D versus placebo supplementation on markers of systemic inflammation in hypertensive patients.
Nutr Metab Cardiovasc Dis. 2021; 31(11):3202-3209 Doi: 10.1016/j.numecd.2021.07.028
Web of Science PubMed FullText FullText_MUG

 

** Schrom, S; Hebesberger, T; Wallner, SA; Anders, I; Richtig, E; Brandl, W; Hirschmugl, B; Garofalo, M; Bernecker, C; Schlenke, P; Kashofer, K; Wadsack, C; Aigelsreiter, A; Heitzer, E; Riedl, S; Zweytick, D; Kretschmer, N; Richtig, G; Rinner, B MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy.
Int J Mol Sci. 2021; 22(21): Doi: 10.3390/ijms222111318 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Wagner, NB; Lenders, MM; Kühl, K; Reinhardt, L; André, F; Dudda, M; Ring, N; Ebel, C; Stäger, R; Zellweger, C; Lang, R; Paar, M; Gussek, P; Richtig, G; Stürmer, SH; Kimeswenger, S; Oellinger, A; Forschner, A; Leiter, U; Weide, B; Gassenmaier, M; Schraag, A; Klumpp, B; Hoetzenecker, W; Berking, C; Richtig, E; Ziemer, M; Mangana, J; Terheyden, P; Loquai, C; Nguyen, VA; Gebhardt, C; Meier, F; Diem, S; Cozzio, A; Flatz, L; Röcken, M; Garbe, C; Eigentler, TK Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study.
J Immunother Cancer. 2021; 9(5): e002350 Doi: 10.1136/jitc-2021-002350 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Richtig, G; Cerroni, L; Schmidt, H; Beham-Schmid, C; Deinlein, T; Vallant, C; Richtig, E Talimogene laherparepvec can initiate plasma cell invasion into infiltrated melanoma lesions - a case series.
J Eur Acad Dermatol Venereol. 2021; 35(3):e209-e211 Doi: 10.1111/jdv.16922
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Sarif, Z; Dogan, A; Richtig, G; Fechner, H; Kreppel, F; Eberle, J Mcl-1 inhibition enhances the proapoptotic effects of vemurafenib in melanoma cells
EXP DERMATOL. ABSTRACT. 2021; 30(3):E106-E106.-47th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF); MAR 4-6, 2021; Virtuell, DEUTSCHLAND. [Poster]
Web of Science

 

2020

Originalarbeit (Zeitschrift)

** Richtig, G; Richtig, E; Neiss, AN; Quehenberger, F; Gmainer, DG; Kamolz, LP; Lumenta, DB Does the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study.
Int J Surg. 2020; 75:160-164 Doi: 10.1016/j.ijsu.2020.01.146
Web of Science PubMed FullText FullText_MUG

 

** Theiler-Schwetz, V; Trummer, C; Richtig, E; Richtig, G; Pilz, S Thyroid disorders during immune checkpoint inhibitor therapy.
AUST J CLIN ENDOCR M. 2020; Doi: 10.1007/s41969-020-00111-y [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

2019

Originalarbeit (Zeitschrift)

** Richtig, G; Aigelsreiter, AM; Asslaber, M; Weiland, T; Pichler, M; Eberhard, K; Sygulla, S; Schauer, S; Hoefler, G; Aigelsreiter, A Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma.
Histopathology. 2019; 75(1):118-127 Doi: 10.1111/his.13860 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Richtig, E; Böhm, A; Oing, C; Bozorgmehr, F; Kruger, S; Kiesewetter, B; Zielinski, C; Berghoff, AS Awareness of predatory journals and open access among medical oncologists: results of an online survey.
ESMO Open. 2019; 4(6): e000580-e000580. Doi: 10.1136/esmoopen-2019-000580 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Richtig, M; Hoetzenecker, W; Saxinger, W; Lange-Asschenfeldt, B; Steiner, A; Strohal, R; Posch, C; Bauer, JW; Müllegger, RR; Deinlein, T; Sepp, N; Volc-Platzer, B; Nguyen, VA; Schmuth, M; Hoeller, C; Pregartner, G; Richtig, E Knowledge and Influence of Predatory Journals in Dermatology: A Pan-Austrian Survey.
Acta Derm Venereol. 2019; 99(1):58-62 Doi: 10.2340/00015555-3037 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Theiler, A; Bärnthaler, T; Platzer, W; Richtig, G; Peinhaupt, M; Rittchen, S; Kargl, J; Ulven, T; Marsh, LM; Marsche, G; Schuligoi, R; Sturm, EM; Heinemann, A Butyrate ameliorates allergic airway inflammation by limiting eosinophil trafficking and survival.
J Allergy Clin Immunol. 2019; 144(3):764-776 Doi: 10.1016/j.jaci.2019.05.002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Richtig, G; Ramelyte, E; Koch, L; Greinix, H; Ferrone, S; Dummer, R; Richtig, E Unmasking of a primary desmoplastic melanoma tumour in the course of treatment of a metastatic disease with anti-PD-1 monoclonal antibody.
J Eur Acad Dermatol Venereol. 2019; 33(10):e381-e383-e381-e383 Doi: 10.1111/jdv.15675 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Originalarbeit (Zeitschrift)

** Berger, M; Richtig, G; Kashofer, K; Aigelsreiter, A; Richtig, E The window of opportunities for targeted therapy in BRAFwt/NRASwt/KITwt melanoma: biology and clinical implications of fusion proteins and other mutations.
G Ital Dermatol Venereol. 2018; 153(3): 349-360. Doi: 10.23736/S0392-0488.18.05970-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Grübler, MR; Gaksch, M; Kienreich, K; Verheyen, ND; Schmid, J; Müllner, C; Richtig, G; Scharnagl, H; Trummer, C; Schwetz, V; Meinitzer, A; Pieske, B; März, W; Tomaschitz, A; Pilz, S Effects of Vitamin D3 on asymmetric- and symmetric dimethylarginine in arterial hypertension.
J Steroid Biochem Mol Biol. 2018; 175:157-163 Doi: 10.1016/j.jsbmb.2016.12.014
Web of Science PubMed FullText FullText_MUG

 

** Gutschner, T; Richtig, G; Haemmerle, M; Pichler, M From biomarkers to therapeutic targets-the promises and perils of long non-coding RNAs in cancer.
Cancer Metastasis Rev. 2018; 37(1):83-105 Doi: 10.1007/s10555-017-9718-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Richtig, G; Hoeller, C; Wolf, M; Wolf, I; Rainer, BM; Schulter, G; Richtig, M; Grübler, MR; Gappmayer, A; Haidn, T; Kofler, J; Huegel, R; Lange-Asschenfeldt, B; Pichler, M; Pilz, S; Heinemann, A; Richtig, E Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study.
PLoS One. 2018; 13(10):e0204729-e0204729 Doi: 10.1371/journal.pone.0204729 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Richtig, G; Berger, M; Lange-Asschenfeldt, B; Aberer, W; Richtig, E Problems and challenges of predatory journals.
J Eur Acad Dermatol Venereol. 2018; 32(9): 1441-1449. Doi: 10.1111/jdv.15039 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Homicsko, K; Richtig, G; Tuchmann, F; Tsourti, Z; Hanahan, D; Coukos, G; Wind-Rotolo, M; Richtig, E; Zygoura, P; Holler, C; Dafni, U; Michielin, OA Proton pump inhibitors negatively impact survival of PD-1 inhibitor based therapies in metastatic melanoma patients
ANN ONCOL. 2018; 29: 40-40.-ESMO Immuno-Oncology Congress; DEC 13-16, 2018; Geneva, SWITZERLAND. [Oral Communication]
Web of Science FullText

 

** Koeller, M; Berger, M; Eder, S; Richtig, G; Richtig, E; Pichler, M; Winter, G; Hoefler, G; Aigelsreiter, A. Is microsatellite-instability a prognostic factor in melanoma patients treated with immune-checkpoint inhibitors?
VIRCHOWS ARCH. 2018; 473: S9-S10. [Oral Communication]
Web of Science

 

** Theiler, A; Platzer, W; Richtig, G; Peinhaupt, M; Barnthaler, T; Schuligoi, R; Sturm, EM; Heinemann, A Short chain fatty acids (SCFA) activate the intrinsic apoptosis pathway in eosinophils from atopic individuals
ALLERGY. 2018; 73: 89-89.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); MAY 26-30, 2018; Munich, GERMANY. [Poster]
Web of Science

 

2017

Originalarbeit (Zeitschrift)

** Richtig, G; Aigelsreiter, A; Schwarzenbacher, D; Ress, AL; Adiprasito, JB; Stiegelbauer, V; Hoefler, G; Schauer, S; Kiesslich, T; Kornprat, P; Winder, T; Eisner, F; Gerger, A; Stoeger, H; Stauber, R; Lackner, C; Pichler, M SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
PLoS One. 2017; 12(11):e0187814-e0187814 Doi: 10.1371/journal.pone.0187814 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schwab, C; Mayer, C; Zalaudek, I; Riedl, R; Richtig, M; Wackernagel, W; Hofmann-Wellenhof, R; Richtig, G; Langmann, G; Tarmann, L; Wedrich, A; Richtig, E Iris Freckles a Potential Biomarker for Chronic Sun Damage.
Invest Ophthalmol Vis Sci. 2017; 58(6):BIO174-BIO179 Doi: 10.1167/iovs.17-21751
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Richtig, G; Richtig, E; Kashofer, K; Koch, L; Winter, G; Hoefler, G; Pichler, M; Ehall, B; Grübler, MR; Heinemann, A; Aigelsreiter, A Testing and clinical implications for non-V600 BRAF mutations in metastatic NRASmt melanoma.
Br J Dermatol. 2017; 177(3):860-861 Doi: 10.1111/bjd.15222
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Goblirsch, M; Richtig, G; Slaby, O; Berindan-Neagoe, I; Gerger, A; Pichler, M MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.
Pharmacogenomics. 2017; 18(10):1027-1038 Doi: 10.2217/pgs-2017-0004
Web of Science PubMed FullText FullText_MUG

 

** Richtig, G; Ehall, B; Richtig, E; Aigelsreiter, A; Gutschner, T; Pichler, M Function and Clinical Implications of Long Non-Coding RNAs in Melanoma.
Int J Mol Sci. 2017; 18(4): Doi: 10.3390/ijms18040715 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Hoeller, C; Kashofer, K; Aigelsreiter, A; Heinemann, A; Kwong, LN; Pichler, M; Richtig, E Beyond the BRAFV600E hotspot: biology and clinical implications of rare BRAF gene mutations in melanoma patients.
Br J Dermatol. 2017; 177(4):936-944 Doi: 10.1111/bjd.15436
Web of Science PubMed FullText FullText_MUG

 

Kommentar

** Richtig, G; Pichler, M Prediction of Response in Melanoma Therapy by Systemic Inflammatory Response - One Size Fits Not All.
EBioMedicine. 2017; 18(6):13-14 Doi: 10.1016/j.ebiom.2017.03.032 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Aigelsreiter, AM; Sygulla, S; Schauer, S; Asslaber, M; Pichler, M; Höfler, G; Aigelsreiter, A Hedgehog pathway proteins SMO and GLI expression in head and neck squamous cell carcinoma – a potential therapeutic target?.
Virchows Arch. 2017; 471: S152-S152.-29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, The Netherlands. [Poster]
Web of Science FullText

 

** Richtig, G; Byrom, L; Kupsa, R; Schaider, H; Hofmann-Wellenhof, R; Wolf, IH; Soyer, HP; Richtig, E Pregnancy as a driver for melanoma.
Br J Dermatol. 2017; 177(3):854-857 Doi: 10.1111/bjd.15124 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Originalarbeit (Zeitschrift)

** Grübler, MR; Gaksch, M; Kienreich, K; Verheyen, N; Schmid, J; Ó, Hartaigh, B; Richtig, G; Scharnagl, H; Meinitzer, A; Fahrleitner-Pammer, A; März, W; Tomaschitz, A; Pilz, S Effects of vitamin D supplementation on glycated haemoglobin and fasting glucose levels in hypertensive patients: a randomized controlled trial.
Diabetes Obes Metab. 2016; 18(10):1006-12 Doi: 10.1111/dom.12709
Web of Science PubMed FullText FullText_MUG

 

** Grübler, MR; Gaksch, M; Kienreich, K; Verheyen, N; Schmid, J; Ó, Hartaigh, BW; Richtig, G; Scharnagl, H; Meinitzer, A; Pieske, B; Fahrleitner-Pammer, A; März, W; Tomaschitz, A; Pilz, S Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial.
J Clin Hypertens (Greenwich). 2016; 18(7):608-13 Doi: 10.1111/jch.12825 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Deinlein, T; Richtig, G; Schwab, C; Scarfi, F; Arzberger, E; Wolf, I; Hofmann-Wellenhof, R; Zalaudek, I Der Einsatz der Dermatoskopie in der Diagnose und Therapie von nichtmelanozytären Hautkrebsformen.
J Dtsch Dermatol Ges. 2016; 14(2): 144-152. Doi: 10.1111/ddg.120_12903 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Deinlein, T; Richtig, G; Schwab, C; Scarfi, F; Arzberger, E; Wolf, I; Hofmann-Wellenhof, R; Zalaudek, I The use of dermatoscopy in diagnosis and therapy of nonmelanocytic skin cancer.
J Dtsch Dermatol Ges. 2016; 14(2):144-151 Doi: 10.1111/ddg.12903
PubMed FullText FullText_MUG

 

** Richtig, E; Trapp, M; Kapfhammer, HP; Jenull, B; Richtig, G; Trapp, EM The Importance of a Biopsychosocial Approach in Melanoma ResearchExperiences from a Single-center Multidisciplinary Melanoma Working Group in Middle-Europe.
Acta Derm Venereol. 2016; 96(217):51-54 Doi: 10.2340/00015555-2426 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fallbericht

** Richtig, G; Aigelsreiter, A; Kashofer, K; Talakic, E; Kupsa, R; Schaider, H; Richtig, E Two Case Reports of Rare BRAF Mutations in Exon 11 and Exon 15 with Discussion of Potential Treatment Options.
Case Rep Oncol. 2016; 9(3):543-546 Doi: 10.1159/000449125 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Richtig, G; Ehall, B; Koch, L; Richtig, E; Winter, G; Eder, S; Kashofer, K; Heinemann, A; Hoefler, G; Aigelsreiter, A The clinical relevance of testing for non-V600E BRAF mutations in melanoma-a single center experience
VIRCHOWS ARCH. 2016; 469: S309-S309. [Oral Communication]
Web of Science

 

** Riding, G; Ehall, B; Koch, L; Richtig, E; Winter, G; Eder, S; Kashofer, K; Heinemann, A; Hoefler, G; Aigelsreiter, A The relevance of BRAF exon 11 testing in melanoma-single center experience
VIRCHOWS ARCH. 2016; 469: S193-S193. [Poster]
Web of Science

 

** Theiler, A; Richtig, G; Frei, R; Platzer, W; Schuligoi, R; Heinemann, A Short chain fatty (SCFA) acids induce apoptosis in peripheral blood eosinophils and promote endothelial barrier function
ALLERGY. 2016; 71: 148-148.-Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 11-15, 2016; Vienna, AUSTRIA. [Poster]
Web of Science

 

2014

Originalarbeit (Zeitschrift)

** Richtig, G; Richtig, E; Massone, C; Hofmann-Wellenhof, R Analysis of clinical, dermoscopic and histopathological features of primary melanomas of patients with metastatic disease--a retrospective study at the Department of Dermatology, Medical University of Graz, 2000-2010.
J Eur Acad Dermatol Venereol. 2014; 28(12):1776-1781 Doi: 10.1111/jdv.12413
Web of Science PubMed FullText FullText_MUG

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum